查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1986581

美国製药隔离器市场：市场规模、份额和趋势分析（按产品和类型）、消费行为和竞争分析以及细分市场预测（2026-2033 年）

U.S. Pharmaceutical Isolators Market Size, Share & Trends Analysis Report By Product (Positive Pressure, Negative Pressure), By Type (Open Isolator, Closed Isolator), Consumer Behavior And Competitive Analysis, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国製药隔离器市场概述

据估计，2025 年美国医药隔离器市值为 1.773 亿美元，预计到 2033 年将达到 2.76 亿美元，2026 年至 2033 年的复合年增长率为 5.9%。

美国製药隔离器产业的驱动力是不断增加的监管压力，以确保药品生产和分发过程中的高无菌性和工人安全。

针对危险药品无菌处理和操作的更严格指导方针，医疗机构和生产商正被迫实施密封、严格控制的系统。另一个主要驱动因素是生物製药、细胞和基因疗法以及高活性药物的快速增长，这些药物需要严格的环境控制。这些治疗方法对污染高度敏感，且通常涉及危险物质，因此对先进的隔离解决方案的需求不断增长。自动化消毒和模组化隔离器设计等技术进步也提高了设备的易用性和普及率。这些因素共同推动了已开发市场和新兴市场对药品隔离器的投资。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：美国製药隔离器市场：影响因素、趋势与范围

  • 采用率和成长率预测：地图
  • 产业价值链分析
  • 法律规范
  • 市场动态
  • 产业分析工具
    • 波特五力分析
    • 宏观环境分析
  • 宏观经济趋势分析

第四章：美国製药隔离器市场：产品特定预测与趋势分析

  • 波动分析及市场份额：按产品划分（2025-2033 年）
  • 美国製药隔离器市场估算与预测：按产品分类（2021-2033 年）
  • 正压
  • 负压

第五章：美国製药隔离器市场：按类型分類的估算和趋势分析

  • 波动分析及市场份额：按类型划分（2025-2033 年）
  • 美国製药隔离器市场估算与预测：按类型划分（2021-2033 年）
  • 开放式隔离器
  • 闭式隔离器

第六章：美国製药隔离器市场：竞争格局

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司分类
  • 企业市场定位
  • 竞争对手仪錶板分析
  • 企业热力图分析（2025 年）
  • 策略规划
    • 业务拓展
    • 企业合併（M&A）
    • 伙伴关係和联盟
    • 新产品发布
  • 公司简介
    • NuAire, Inc.
    • Germfree
    • Esco Micro Pte. Ltd.
    • Bioquell, An Ecolab Solution
    • Labconco
    • Howorth Air Technology Limited
    • Containment Technologies Group, Inc.
    • Terra Universal. Inc.
    • The Baker Company
    • Schaefer Technologies
Product Code: GVR-4-68039-540-4

U.S. Pharmaceutical Isolators Market Summary

The U.S. pharmaceutical isolators market size was estimated at USD 177.3 million in 2025 and is projected to reach USD 276.0 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. The U.S. pharmaceutical isolators industry is being driven by growing regulatory pressure to ensure higher sterility assurance and operator safety in drug manufacturing and compounding.

Stricter guidelines on aseptic processing and hazardous drug handling are pushing healthcare facilities and manufacturers to adopt closed, well-controlled systems. Another key driver is the rapid growth of biologics, cell and gene therapies, and high-potency drugs that require tightly controlled environments. These therapies are highly sensitive to contamination and often involve hazardous materials, increasing demand for advanced containment solutions. Technological improvements such as automated decontamination and modular isolator designs are also improving usability and adoption. Together, these factors are accelerating investment in pharmaceutical isolators across both developed and emerging markets.

U.S. Pharmaceutical Isolators Market Report Segmentation

This report forecasts revenue growth at the U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pharmaceutical isolators market report based on product, type.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Positive Pressure
  • Negative Pressure
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Open Isolator
  • Closed Isolator

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Isolators Market Variables, Trends & Scope

  • 3.1. Concentration & Growth Prospect Mappin
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Market Challenge Analysis
    • 3.4.4. Market Opportunity Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macro-environmental Analysis
  • 3.6. Economic Mega Trend Analysis

Chapter 4. U.S. Pharmaceutical Isolators Market: Product Estimates & Trend Analysis

  • 4.1. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Product, 2021 to 2033 (USD Million)
  • 4.3. Positive Pressure
    • 4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4. Negative Pressure
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pharmaceutical Isolators Market: Type Estimates & Trend Analysis

  • 5.1. Type Movement Analysis & Market Share, 2025 & 2033
  • 5.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Type, 2021 to 2033 (USD Million)
  • 5.3. Open Isolator
    • 5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4. Closed Isolator
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pharmaceutical Isolators Market - Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Positioning
  • 6.4. Competitive Dashboard Analysis
  • 6.5. Company Heat Map Analysis, 2025
  • 6.6. Strategy Mapping
    • 6.6.1. Expansion
    • 6.6.2. Mergers & Acquisition
    • 6.6.3. Partnerships & Collaborations
    • 6.6.4. New Product Launches
  • 6.7. Company Profiles
    • 6.7.1. NuAire, Inc.
      • 6.7.1.1. Participant's overview
      • 6.7.1.2. Financial performance
      • 6.7.1.3. Product benchmarking
      • 6.7.1.4. Recent developments
    • 6.7.2. Germfree
      • 6.7.2.1. Participant's overview
      • 6.7.2.2. Financial performance
      • 6.7.2.3. Product benchmarking
      • 6.7.2.4. Recent developments
    • 6.7.3. Esco Micro Pte. Ltd.
      • 6.7.3.1. Participant's overview
      • 6.7.3.2. Financial performance
      • 6.7.3.3. Product benchmarking
      • 6.7.3.4. Recent developments
    • 6.7.4. Bioquell, An Ecolab Solution
      • 6.7.4.1. Participant's overview
      • 6.7.4.2. Financial performance
      • 6.7.4.3. Product benchmarking
      • 6.7.4.4. Recent developments
    • 6.7.5. Labconco
      • 6.7.5.1. Participant's overview
      • 6.7.5.2. Financial performance
      • 6.7.5.3. Product benchmarking
      • 6.7.5.4. Recent developments
    • 6.7.6. Howorth Air Technology Limited
      • 6.7.6.1. Participant's overview
      • 6.7.6.2. Financial performance
      • 6.7.6.3. Product benchmarking
      • 6.7.6.4. Recent developments
    • 6.7.7. Containment Technologies Group, Inc.
      • 6.7.7.1. Participant's overview
      • 6.7.7.2. Financial performance
      • 6.7.7.3. Product benchmarking
      • 6.7.7.4. Recent developments
    • 6.7.8. Terra Universal. Inc.
      • 6.7.8.1. Participant's overview
      • 6.7.8.2. Financial performance
      • 6.7.8.3. Product benchmarking
      • 6.7.8.4. Recent developments
    • 6.7.9. The Baker Company
      • 6.7.9.1. Participant's overview
      • 6.7.9.2. Financial performance
      • 6.7.9.3. Product benchmarking
      • 6.7.9.4. Recent developments
    • 6.7.10. Schaefer Technologies
      • 6.7.10.1. Participant's overview
      • 6.7.10.2. Financial performance
      • 6.7.10.3. Product benchmarking
      • 6.7.10.4. Recent developments

List of Tables

  • Table 1 U.S. pharmaceutical isolators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Table 2 U.S. pharmaceutical isolators market estimates and forecasts by product, 2021 - 2033 (USD Million)
  • Table 3 U.S. pharmaceutical isolators market estimates and forecasts by type, 2021 - 2033 (USD Million)
  • Table 4 Recent Developments & Impact Analysis, By Key Market Participants
  • Table 5 Company Heat Map Analysis, 2025

List of Figures

  • Fig. 1 Market Segmentation & Scope
  • Fig. 2 Information Procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Data Validating & Publishing
  • Fig. 6 Market Snapshot
  • Fig. 7 Product Segment Snapshot
  • Fig. 8 Type Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 US Pharmaceutical Isolators Market Value, 2025 (USD Million)
  • Fig. 11 Market Concentration & Growth Prospect Mapping
  • Fig. 12 Value Chain Analysis
  • Fig. 13 U.S. Pharmaceutical Isolators Market: PORTER's Analysis
  • Fig. 14 U.S. Pharmaceutical Isolators Market: PESTEL Analysis
  • Fig. 15 U.S. Pharmaceutical Isolators Market, By Product: Key Takeaways
  • Fig. 16 U.S. Pharmaceutical Isolators Market: Product Movement Analysis & Market Share, 2025 & 2033
  • Fig. 17 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, By Negative Pressure, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, By Positive Pressure, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Pharmaceutical Isolators Market, By Type: Key Takeaways
  • Fig. 20 U.S. Pharmaceutical Isolators Market: Type Movement Analysis & Market Share, 2025 & 2033
  • Fig. 21 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, In Open Isolator, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, In Closed Isolator, 2021 - 2033 (USD Million)
  • Fig. 23 Key Company/Competition Categorization
  • Fig. 24 Competitive Dashboard Analysis
  • Fig. 25 Company Market Positioning
  • Fig. 26 Strategic Framework